Correction: Patient-reported outcomes of upadacitinib versus abatacept in patients with rheumatoid arthritis and an inadequate response to biologic disease-modifying antirheumatic drugs: 12- and 24-week results of a phase 3 trial

Saved in:
Bibliographic Details
Published inArthritis research & therapy Vol. 24; no. 1; p. 1
Main Authors Bergman, Martin, Tundia, Namita, Martin, Naomi, Suboticki, Jessica L., Patel, Jayeshkumar, Goldschmidt, Debbie, Song, Yan, Wright, Grace C.
Format Journal Article
LanguageEnglish
Published London BioMed Central Ltd 03.11.2022
BioMed Central
BMC
Online AccessGet full text

Cover

More Information
Bibliography:correction
ObjectType-Correction/Retraction-1
SourceType-Scholarly Journals-1
content type line 14
content type line 23
ISSN:1478-6362
1478-6354
1478-6362
DOI:10.1186/s13075-022-02940-5